clinical trial · NCT06554873
Adaptive Use of Nicotine Substitution to Maintain Smoking Reduction/Abstinence in Nicotine Responders
Rose Research Center, LLC·phase3·completed·n = 150
Smoking CessationHarm ReductionNicodermNicorette 4Mg Chewing GumNicorette Lozenge ProductNJOY e-cigaretteon!
brief summary
To determine whether smokers who initially respond (within 2 weeks) to nicotine products (including nicotine replacement therapy, e-cigarettes, nicotine pouches) by reducing their smoking by ≥50% can be successfully maintained on use of these noncombustible nicotine alternatives to cigarettes for 6 months, and whether this results in sustained smoking reduction/abstinence.
started
Aug 29, 2024
primary completion
Dec 9, 2025
completion
Dec 9, 2025
last updated
Feb 6, 2026
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol